PET imaging of the autonomic myocardial function: methods and interpretation

Clinical and Translational Imaging

Volumn 3, Issue 5, 2015, Pages 365-372

  Noordzij, Walter ^a   Slart, Riemer H J A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Interpretation; Methods; Myocardial innervation; PET

Indexed keywords

11 C CGP 12177; ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; META HYDROXYEPHINEPHRINE C 11; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VESICULAR ACETYLCHOLINE TRANSPORTER;

DRUG UPTAKE; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HUMAN; IMAGE ANALYSIS; NERVE FUNCTION; PHASE 1 CLINICAL TRIAL (TOPIC); PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW; SYMPATHETIC INNERVATION;

EID: 84952993971     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-015-0139-6     Document Type: Review

References (37)

1. Werner RA, Rischpler C, Onthank D, Lapa C, Robinson S, Sammnick S, Javadi M, Schwaiger M, Nekolla SG, Higuchi T (2015) Retention kinetics of the 18F-labeled sympathetic nerve PET tracer LMI1195: comparison with 11C-HED and 123I-MIBG. J Nucl Med 56(9):1429–1433
2. Christensen TE, Kjaer A, Hasbak P (2014) The clinical value of cardiac sympathetic imaging in heart failure. Clin Physiol Funct Imaging 34:178–182
3. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, Agostini D, Weiland F, Chandna H, Narula J, ADMIRE-HF Investigators (2010) Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 55:2212–2221
4. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, Hutson AD, Dekemp RA, Haka MS, Sajjad M, Cimato TR, Curtis AB, Cain ME, Canty JM Jr (2014) Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol 63:141–149
5. Investigators AVID (1999) Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 34:1552–1559
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH, Sudden CardiacDeathin Heart Failure Trial (SCD-HeFT) Investigators (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
7. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, Trial Multicenter Automatic Defibrillator Implantation, Investigators II (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
8. Raffel DM, Corbett JR, del Rosario RB, Gildersleeve DL, Chiao PC, Schwaiger M, Wieland DM (1996) Clinical evaluation of carbon-11-phenylephrine: MAO-sensitive marker of cardiac sympathetic neurons. J Nucl Med 37:1923–1931
9. Tipre DN, Fox JJ, Holt DP, Green G, Yu J, Pomper M, Dannals RF, Bengel FM (2008) In vivo PET imaging of cardiac presynaptic sympathoneuronal mechanisms in the rat. J Nucl Med 49:1189–1195
10. Yu M, Bozek J, Lamoy M, Guaraldi M, Silva P, Kagan M, Yalamanchili P, Onthank D, Mistry M, Lazewatsky J, Broekema M, Radeke H, Purohit A, Cdebaca M, Azure M, Cesati R, Casebier D, Robinson SP (2011) Evaluation of LMI1195, a novel 18F-labeled cardiac neuronal PET imaging agent, in cells and animal models. Circ Cardiovasc Imaging 4:435–443
11. Sinusas AJ, Lazewatsky J, Brunetti J, Heller G, Srivastava A, Liu YH, Sparks R, Puretskiy A, Lin SF, Crane P, Carson RE, Lee LV (2014) Biodistribution and radiation dosimetry of LMI1195: first-in-human study of a novel 18F-labeled tracer for imaging myocardial innervation. J Nucl Med 55:1445–1451
12. Bohm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E (1988) Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9:844–852
13. Brodde OE, Hillemann S, Kunde K, Vogelsang M, Zerkowski HR (1992) Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure. J Heart Lung Transplant 11:S164–S174
14. Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR (2008) Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 49:234–241
15. Elsinga PH, van Waarde A, Visser TJ, Vaalburg W (1998) Visualization of β-adrenoceptors using PET. Clin Pos Imaging 1:81–94
16. Elsinga PH, Van Waarde A, Visser GM, Vaalburg W (1994) Synthesis and preliminary evaluation of (R, S)-1-[2-((carbamoyl-4-hydroxy)phenoxy)-ethylamino]-3-[4-(1-[11C]-met hyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol ([11C]CGP 20712A) as a selective beta 1-adrenoceptor ligand for PET. Nucl Med Biol 21:211–217
17. Doze P, Elsinga PH, van Waarde A, Pieterman RM, Pruim J, Vaalburg W, Willemsen AT (2002) Quantification of beta-adrenoceptor density in the human heart with (S)-[11C]CGP12388 and a tracer kinetic model. Eur J Nucl Med Mol Imaging 29:295–304
18. Law MP, Wagner S, Kopka K, Renner C, Pike VW, Schober O, Schäfers M (2010) Preclinical evaluation of an 18F-labelled beta1-adrenoceptor selective radioligand based on ICI 89,406. Nucl Med Biol 37:517–552
19. Kenk M, Greene M, Thackeray J, deKemp RA, Lortie M, Thorn S, Beanlands RS, DaSilva JN (2007) In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues. Nucl Med Biol 34:71–77
20. Kenk M, Greene M, Lortie M, Dekemp RA, Beanlands RS, Dasilva JN (2008) Use of a column-switching high-performance liquid chromatography method to assess the presence of specific binding of (R)- and (S)-[(11)C]rolipram and their labeled metabolites to the phosphodiesterase-4 enzyme in rat plasma and tissues. Nucl Med Biol 35:515–521
21. Thackeray JT, DaSilva JN, Elsinga PH (2015) Tracers for sympathetic cardiac neurotransmission imaging. In: Slart RHJA, Tio RA, Elsinga PH, Schwaiger M (eds) Autonomic innervation of the heart, 1st edn. Springer, Heidelberg, pp 87–109
22. Gómez-Vallejo V, González-Esparza M, Llop J (2012) Facile and improved synthesis of[11C]MeQNB. J Labelled Comp Radiopharm 55:470–473
23. Sullivan JP, Donnelly-Roberts D, Briggs CA, Anderson DJ, Gopalakrishnan M, Piattoni-Kaplan M, Campbell JE, McKenna DG, Molinari E, Hettinger AM, Garvey DS, Wasicak JT, Holladay MW, Williams M, Arneric SP (1996) A-85380 [3-(2(S)-azetidinylmethoxy) pyridine]: in vitro pharmacological properties of a novel, high affinity alpha 4 beta 2 nicotinic acetylcholine receptor ligand. Neuropharmacology 35:725–734
24. DeGrado TR, Mulholland GK, Wieland DM, Schwaiger M (1994) Evaluation of (-)[18F]fluoroethoxybenzovesamicol as a new PET tracer of cholinergic neurons of the heart. Nucl Med Biol 21:189–195
25. Egleton RD, Brown KC, Dasgupta P (2009) Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases. Pharmacol Ther 121:205–223
26. Bucerius J, Manka C, Schmaljohann J, Mani V, Gündisch D, Rudd JH, Bippus R, Mottaghy FM, Wüllner U, Fayad ZA, Biersack HJ (2012) Feasibility of [18F]-2-Fluoro-A85380-PET imaging of human vascular nicotinic acetylcholine receptors in vivo. JACC Cardiovasc Imaging 5:528–536
27. 11C-hydroxyephedrine PET for the simultaneous assessment of cardiac sympathetic and contractile functions. Ann Nucl Med 28:187–195
28. Rosenspire KC, Haka MS, Van Dort ME, Jewett DM, Gildersleeve DL, Schwaiger M, Wieland DM (1990) Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med 31:1328–1334
29. Matsunari I, Aoki H, Nomura Y, Takeda N, Chen WP, Taki J, Nakajima K, Nekolla SG, Kinuya S, Kajinami K (2010) Iodine-123 metaiodobenzylguanidine imaging and carbon-11 hydroxyephedrine positron emission tomography compared in patients with left ventricular dysfunction. Circ Cardiovasc Imaging 3:595–603
30. Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, Deeb M, Wolfe E Jr, Wieland DM (1990) Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82:457–464
31. Delforge J, Mesangeau D, Dolle F, Merlet P, Loc’h C, Bottlaender M, Trebossen R, Syrota A (2002) In vivo quantification and parametric images of the cardiac beta-adrenergic receptor density. J Nucl Med 43:215–226
32. Link JM, Stratton JR, Levy W, Poole JE, Shoner SC, Stuetzle W, Caldwell JH (2003) PET measures of pre- and post-synaptic cardiac beta adrenergic function. Nucl Med Biol 30:795–803
33. John AS, Mongillo M, Depre C, Khan MT, Rimoldi OE, Pepper JR, Dreyfus GD, Pennell DJ, Camici PG (2007) Pre- and post-synaptic sympathetic function in human hibernating myocardium. Eur J Nucl Med Mol Imaging 34:1973–1980
34. Wichter T, Schäfers M, Rhodes CG, Borggrefe M, Lerch H, Lammertsma AA, Hermansen F, Schober O, Breithardt G, Camici PG (2000) Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricularcardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101(13):1552–1558
35. Nekolla SG, Rischpler C (2015) General principles of PET/CT and autonomic innervation of the heart including kinetics and software. In: Slart RHJA, Tio RA, Elsinga PH, Schwaiger M (eds) autonomic innervation of the heart, 1st edn. Springer, Heidelberg, pp 161–185
36. Sweeney MO, Ruskin JN (1994) Mortality benefits and the implantable cardioverter-defibrillator. Circulation 89:1851–1858
37. De Jong RM, Willemsen AT, Slart RH, Blanksma PK, van Waarde A, Cornel JH, Vaalburg W, van Veldhuisen DJ, Elsinga PH (2005) Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. Eur J Nucl Med Mol Imaging 32:443–447